| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/15/2015 | US20150017120 Synergistic tumor treatment with extended-pk il-2 and adoptive cell therapy |
| 01/15/2015 | US20150017105 Anhydrous hydrogel composition and delivery system |
| 01/15/2015 | US20150017095 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| 01/15/2015 | US20150017091 Detection and treatment of metastatic disease |
| 01/14/2015 | EP2824190A1 Methods and compositions for generation of germline human antibody genes |
| 01/14/2015 | EP2824183A1 Antibody substituting for function of blood coagulation factor VIII |
| 01/14/2015 | EP2824114A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 01/14/2015 | EP2824113A1 Biomarker for selecting a subject for application of an anti-c-Met antibody |
| 01/14/2015 | EP2824112A1 Method for inducing proliferation of Natural Killer cells by mobile nanomatrices |
| 01/14/2015 | EP2824111A2 Anti-C5A Antibodies and Methods for Using the Antibodies |
| 01/14/2015 | EP2823821A1 Antibody specifically binding to digoxigenin |
| 01/14/2015 | EP2823304A1 Sandwich assay for immunosuppressant drugs |
| 01/14/2015 | EP2822971A1 Compositions for inhibition of quiescin sulfhydryl oxidase (qsox1) and uses of same |
| 01/14/2015 | EP2822970A1 Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof |
| 01/14/2015 | EP2822969A1 Prevention of infection |
| 01/14/2015 | EP2822968A1 Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof |
| 01/14/2015 | EP2822967A1 Compositions comprising secretory-like immunoglobulins |
| 01/14/2015 | EP2822966A1 Treatment of mucositis with immunoglobulin |
| 01/14/2015 | EP2822965A1 Process for enriching iga |
| 01/14/2015 | EP2822597A1 Chemical modification of antibodies |
| 01/14/2015 | EP2822596A1 Anti-p-selectin antibody formulation |
| 01/14/2015 | EP2822594A1 Methods of treatment with angiopoietin-2 antibodies |
| 01/14/2015 | EP2822592A1 Tgf- 1 specific antibodies and methods and uses thereof |
| 01/14/2015 | EP2822591A1 Pharmaceutical formulations of tnf-alpha antibodies |
| 01/14/2015 | EP2822590A1 Il-17 antibody formulation |
| 01/14/2015 | EP2822588A1 Combination therapy of antibodies against human csf-1r and uses thereof |
| 01/14/2015 | EP2822583A2 Neisseria meningitidis compositions and methods thereof |
| 01/14/2015 | EP2822575A1 Engineered antibody-interferon mutant fusion molecules |
| 01/14/2015 | EP2822379A1 Common light chain mouse |
| 01/14/2015 | CN104284903A 抗磷脂酶d4抗体 Antiphospholipid antibody enzyme d4 |
| 01/14/2015 | CN104284676A 用于纯化单克隆抗体的结晶方法 Crystallization process for purification of monoclonal antibodies |
| 01/14/2015 | CN104284675A 具有抗肿瘤活性的新颖结合分子 Novel anti-tumor activity of binding molecules |
| 01/14/2015 | CN104278038A 一种抗人血管内皮生长因子人源化抗体可变区编码基因及其应用 An anti-human VEGF humanized antibody variable region gene and its application |
| 01/14/2015 | CN104278013A 一种抗人组织转谷氨酰胺酶2的单克隆抗体及其应用 An anti-human tissue transglutaminase 2 monoclonal antibody and its application |
| 01/14/2015 | CN104277119A 重组草鱼IL-1β拮抗蛋白及其编码基因、制备方法、用途 Recombinant IL-1β antagonist carp and its coding gene, preparation, use |
| 01/14/2015 | CN104277110A 一种针对人Tudor-SN蛋白T73位点的应激磷酸化抗体制备方法 One for human Tudor-SN T73 bit of stress protein phosphorylation antibody preparation point |
| 01/14/2015 | CN104277109A 一种针对人Tudor-SN蛋白T103位点的应激磷酸化抗体制备方法 One for human Tudor-SN T103 bit of stress protein phosphorylation antibody preparation point |
| 01/14/2015 | CN104277108A 一种磺胺二甲基嘧啶卵黄抗体的制备方法 A method for preparing dimethyl pyrimidine sulfonamides yolk antibody |
| 01/14/2015 | CN104277107A 一种沃尼妙林卵黄抗体的制备方法 A method for preparing valnemulin yolk antibody |
| 01/14/2015 | CN104277096A 抗人髓系相关分化标志蛋白的单克隆抗体ds6及其应用 Anti-human myeloid differentiation markers associated protein monoclonal antibody and its application ds6 |
| 01/14/2015 | CN104277095A 抗人髓系相关分化标志蛋白的单克隆抗体fma1及其应用 Anti-human myeloid differentiation markers associated protein monoclonal antibody and its application fma1 |
| 01/14/2015 | CN103319593B 一种抗StxII单克隆抗体 An anti StxII monoclonal antibody |
| 01/14/2015 | CN103288965B 一种多氯联苯单克隆抗体的制备方法 One kind of monoclonal antibody preparation PCBs |
| 01/14/2015 | CN103242448B 一种全人源化抗pd-1单克隆抗体及其制备方法和应用 One kind of fully human anti-pd-1 monoclonal antibody and its preparation method and application |
| 01/14/2015 | CN103160474B 肠道病毒71型病毒株、疫苗、动物模型建立方法 Enterovirus 71 virus strains, vaccines, animal model method |
| 01/14/2015 | CN103102392B 一种维甲酸诱导蛋白16n端多肽及其抗体的制备方法和应用 One kind of retinoic acid-inducible protein 16n terminal peptide antibody and its preparation method and application of |
| 01/14/2015 | CN102892782B 针对人类巨细胞病毒的结合成员 A binding member of the human cytomegalovirus |
| 01/14/2015 | CN102471380B 抗FcRH5抗体和免疫偶联物及使用方法 Anti FcRH5 antibodies and immune conjugates and method of use |
| 01/14/2015 | CN102378767B 抗-fgfr3抗体及其使用方法 Anti -fgfr3 antibodies and methods of use |
| 01/14/2015 | CN102083858B 抗il-17a/il-17f交叉反应性抗体及其使用方法 Anti-il-17a / il-17f cross-reactive antibodies and methods of use |
| 01/14/2015 | CN102027013B 细胞外基质蛋白的氨基酸序列rgd的特异性人源化抗体及其应用 The amino acid sequence of extracellular matrix proteins rgd specific humanized antibodies and Applications |
| 01/14/2015 | CN101979404B H5亚型禽流感病毒保守中和表位模拟肽及其用途 H5 subtype avian influenza virus conserved neutralization epitope mimetics and their use |
| 01/14/2015 | CN101939334B C型肝炎病毒抗体 Hepatitis C virus antibodies |
| 01/14/2015 | CN101048427B 抗体或其片段的结晶 Crystallized antibody or fragment thereof |
| 01/13/2015 | US8933300 Elongase gene, and process for the preparation of polyunsaturated fatty acids |
| 01/13/2015 | US8933211 Growth factor isoform |
| 01/13/2015 | US8933206 Benzimidazole compounds and their use as chromatographic ligands |
| 01/13/2015 | US8933205 Process for preparing purified drug conjugates |
| 01/13/2015 | US8933204 Process for the industrial-scale purification of gamma globulins from human plasma for industrial applications |
| 01/13/2015 | US8933203 Vault and vault-like carrier molecules |
| 01/13/2015 | US8933202 AXL antibodies |
| 01/13/2015 | US8933199 Fibronectin based scaffold domain proteins that bind to myostatin |
| 01/13/2015 | US8933034 Chimeric neuregulins and method of making and use thereof |
| 01/13/2015 | US8933030 Treatments for gastrointestinal disorders |
| 01/13/2015 | US8932852 Compositions and methods of treating inflammatory bowel disease |
| 01/13/2015 | US8932830 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/13/2015 | US8932825 Method to engineer mammalian-type carbohydrate structures |
| 01/13/2015 | US8932821 NOGO receptor binding protein |
| 01/13/2015 | US8932715 Precipitation stabilising compositions comprising bioactive molecule and at least one cationic and one anionic precipitation stabilizing additives |
| 01/13/2015 | US8932603 Modified antibody |
| 01/13/2015 | US8932597 Human M2e peptide immunogens |
| 01/13/2015 | US8932593 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 01/13/2015 | US8932592 Compositions and methods for treating inflammatory disorders |
| 01/13/2015 | US8932591 Formulation of human antibodies for treating TNF-α associated disorders |
| 01/13/2015 | US8932589 Methods and compositions using Kloto-FGF23 fusion polypeptides |
| 01/13/2015 | US8932588 Treatment of cancer involving mutated KRAS or BRAF genes |
| 01/13/2015 | US8932586 Modified forms of Pseudomonas exotoxin A |
| 01/13/2015 | CA2623429C Interleukin-13 antibody composition |
| 01/13/2015 | CA2603775C Method of protecting against staphylococcal infection |
| 01/13/2015 | CA2602028C Method for isolation of soluble polypeptides |
| 01/13/2015 | CA2591297C Il-7 variants with reduced immunogenicity |
| 01/13/2015 | CA2558718C Anti-human tenascin monoclonal antibody |
| 01/13/2015 | CA2545325C Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 01/13/2015 | CA2521402C Pectate lyases, nucleic acids encoding them and methods for making and using them |
| 01/13/2015 | CA2489410C Molecular antigen arrays |
| 01/08/2015 | WO2015003156A1 Compositions and methods for treatment of stroke |
| 01/08/2015 | WO2015003122A2 Regulation of glucose metabolism using anti-cgrp antibodies |
| 01/08/2015 | WO2015003114A1 Soluble mic neutralizing monoclonal antibody for treating cancer |
| 01/08/2015 | WO2015002931A1 Compositions and methods for treating obesity |
| 01/08/2015 | WO2015002929A1 Methods and compositions for treating obesity |
| 01/08/2015 | WO2015001532A1 Inhibition of the synthesis of beta-app or of the activity of the a‑beta peptide in the choroid plexus |
| 01/08/2015 | WO2015001510A1 Transgenic non-human mammal for producing chimeric human immunoglobulin e antibodies |
| 01/08/2015 | WO2015001356A1 Cadherin 15 agonists |
| 01/08/2015 | WO2015001277A1 Affinity chromatography matrix |
| 01/08/2015 | WO2015001085A1 Humanized or chimeric cd3 antibodies |
| 01/08/2015 | WO2015001078A1 A new fusion protein to target and treat acute myloid leukemia cells |
| 01/08/2015 | WO2015001049A1 O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof |
| 01/08/2015 | WO2015001033A1 Process for the mono- and bi-sialylation of glycoproteins employing n-terminally truncated beta-galactoside alpha-2,6-sialyltransferase mutants |
| 01/08/2015 | WO2015001015A1 Actively transported and protease-resistant peptides as bbb shuttles and shuttle-cargo constructs |
| 01/08/2015 | WO2015001013A2 Human anti-ifn-alpha antibodies |